After-Hours Stock Movers 03/11: (CFRX) (NVAX) (FNKO) Higher; (MRKR) (POSH) (ULTA) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cyclacel Pharma (CYCC) Prices 1.807M Share Common Offering at $7/Sh
March 12, 2021 8:31 AM ESTCyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the pricing of an underwritten public offering of 1,807,143 shares of its common stock, offered at a price of $7.00 to the public. Additionally, the Company has granted the underwriters a 30-day option to purchase up to an additional 271,071 shares of common stock at the public... More
Marker Therapeutics (MRKR) Prices 28.572M Share Common Offering at $1.75/Sh
March 12, 2021 8:02 AM ESTMarker Therapeutics, Inc. (NASDAQ: MRKR) today announced the pricing of an underwritten public offering of 28,572,000 shares of its common stock at a public offering price of $1.75 per share. The gross proceeds to Marker from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $50.0... More
Funko (FNKO) PT Raised to $17 at DA Davidson
March 12, 2021 6:58 AM ESTDA Davidson analyst Linda Bolton Weiser raised the price target on Funko (NASDAQ: FNKO) to $17.00 (from $7.00) while maintaining a Neutral rating.
The analyst commented, "FNKO reported 4Q20 sales and EBITDA upside surprises, with sales returning to growth (+6%), and the stock was up ~10% after hours.... More
